These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15593317)

  • 1. Mutant torsinA, which causes early-onset primary torsion dystonia, is redistributed to membranous structures enriched in vesicular monoamine transporter in cultured human SH-SY5Y cells.
    Misbahuddin A; Placzek MR; Taanman JW; Gschmeissner S; Schiavo G; Cooper JM; Warner TT
    Mov Disord; 2005 Apr; 20(4):432-440. PubMed ID: 15593317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant cellular behavior of mutant torsinA implicates nuclear envelope dysfunction in DYT1 dystonia.
    Gonzalez-Alegre P; Paulson HL
    J Neurosci; 2004 Mar; 24(11):2593-601. PubMed ID: 15028751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant torsinA, responsible for early-onset torsion dystonia, forms membrane inclusions in cultured neural cells.
    Hewett J; Gonzalez-Agosti C; Slater D; Ziefer P; Li S; Bergeron D; Jacoby DJ; Ozelius LJ; Ramesh V; Breakefield XO
    Hum Mol Genet; 2000 May; 9(9):1403-13. PubMed ID: 10814722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perinuclear biogenesis of mutant torsin-A inclusions in cultured cells infected with tetracycline-regulated herpes simplex virus type 1 amplicon vectors.
    Bragg DC; Camp SM; Kaufman CA; Wilbur JD; Boston H; Schuback DE; Hanson PI; Sena-Esteves M; Breakefield XO
    Neuroscience; 2004; 125(3):651-61. PubMed ID: 15099679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of torsinA on membrane proteins reveals a loss of function and a dominant-negative phenotype of the dystonia-associated DeltaE-torsinA mutant.
    Torres GE; Sweeney AL; Beaulieu JM; Shashidharan P; Caron MG
    Proc Natl Acad Sci U S A; 2004 Nov; 101(44):15650-5. PubMed ID: 15505207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. siRNA knock-down of mutant torsinA restores processing through secretory pathway in DYT1 dystonia cells.
    Hewett JW; Nery FC; Niland B; Ge P; Tan P; Hadwiger P; Tannous BA; Sah DW; Breakefield XO
    Hum Mol Genet; 2008 May; 17(10):1436-45. PubMed ID: 18258738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brainstem pathology in DYT1 primary torsion dystonia.
    McNaught KS; Kapustin A; Jackson T; Jengelley TA; Jnobaptiste R; Shashidharan P; Perl DP; Pasik P; Olanow CW
    Ann Neurol; 2004 Oct; 56(4):540-7. PubMed ID: 15455404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant torsinA interacts with tyrosine hydroxylase in cultured cells.
    O'Farrell CA; Martin KL; Hutton M; Delatycki MB; Cookson MR; Lockhart PJ
    Neuroscience; 2009 Dec; 164(3):1127-37. PubMed ID: 19761814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dystonia-associated protein torsinA modulates synaptic vesicle recycling.
    Granata A; Watson R; Collinson LM; Schiavo G; Warner TT
    J Biol Chem; 2008 Mar; 283(12):7568-79. PubMed ID: 18167355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The BiP molecular chaperone plays multiple roles during the biogenesis of torsinA, an AAA+ ATPase associated with the neurological disease early-onset torsion dystonia.
    Zacchi LF; Wu HC; Bell SL; Millen L; Paton AW; Paton JC; Thomas PJ; Zolkiewski M; Brodsky JL
    J Biol Chem; 2014 May; 289(18):12727-47. PubMed ID: 24627482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of N-linked glycosylation prevents inclusion formation by the dystonia-related mutant form of torsinA.
    Bragg DC; Kaufman CA; Kock N; Breakefield XO
    Mol Cell Neurosci; 2004 Dec; 27(4):417-26. PubMed ID: 15555920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased number of striatal cholinergic interneurons and motor deficits in dopamine receptor 2-expressing-cell-specific Dyt1 conditional knockout mice.
    Yokoi F; Oleas J; Xing H; Liu Y; Dexter KM; Misztal C; Gerard M; Efimenko I; Lynch P; Villanueva M; Alsina R; Krishnaswamy S; Vaillancourt DE; Li Y
    Neurobiol Dis; 2020 Feb; 134():104638. PubMed ID: 31618684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient RNA interference-based knockdown of mutant torsinA reveals reversibility of PERK-eIF2α pathway dysregulation in DYT1 transgenic rats in vivo.
    Beauvais G; Watson JL; Aguirre JA; Tecedor L; Ehrlich ME; Gonzalez-Alegre P
    Brain Res; 2019 Mar; 1706():24-31. PubMed ID: 30366018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and cellular analysis of human variants of the DYT1 dystonia protein, TorsinA/TOR1A.
    Hettich J; Ryan SD; de Souza ON; Saraiva Macedo Timmers LF; Tsai S; Atai NA; da Hora CC; Zhang X; Kothary R; Snapp E; Ericsson M; Grundmann K; Breakefield XO; Nery FC
    Hum Mutat; 2014 Sep; 35(9):1101-13. PubMed ID: 24930953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mislocalization to the nuclear envelope: an effect of the dystonia-causing torsinA mutation.
    Goodchild RE; Dauer WT
    Proc Natl Acad Sci U S A; 2004 Jan; 101(3):847-52. PubMed ID: 14711988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TorsinA binds the KASH domain of nesprins and participates in linkage between nuclear envelope and cytoskeleton.
    Nery FC; Zeng J; Niland BP; Hewett J; Farley J; Irimia D; Li Y; Wiche G; Sonnenberg A; Breakefield XO
    J Cell Sci; 2008 Oct; 121(Pt 20):3476-86. PubMed ID: 18827015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TorsinA participates in endoplasmic reticulum-associated degradation.
    Nery FC; Armata IA; Farley JE; Cho JA; Yaqub U; Chen P; da Hora CC; Wang Q; Tagaya M; Klein C; Tannous B; Caldwell KA; Caldwell GA; Lencer WI; Ye Y; Breakefield XO
    Nat Commun; 2011 Jul; 2():393. PubMed ID: 21750546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dystonia-causing mutant torsinA inhibits cell adhesion and neurite extension through interference with cytoskeletal dynamics.
    Hewett JW; Zeng J; Niland BP; Bragg DC; Breakefield XO
    Neurobiol Dis; 2006 Apr; 22(1):98-111. PubMed ID: 16361107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine release is impaired in a mouse model of DYT1 dystonia.
    Balcioglu A; Kim MO; Sharma N; Cha JH; Breakefield XO; Standaert DG
    J Neurochem; 2007 Aug; 102(3):783-8. PubMed ID: 17550429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-synaptic release deficits in a DYT1 dystonia mouse model.
    Yokoi F; Cheetham CC; Campbell SL; Sweatt JD; Li Y
    PLoS One; 2013; 8(8):e72491. PubMed ID: 23967309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.